Cargando…
Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet’s disease in Japan
BACKGROUND: We hypothesized that Behçet’s disease (BD) consists of several clinical subtypes with different severity, resulting in heterogeneity of the disease. Here, we conducted a study to identify clinical clusters of BD. METHODS: A total of 657 patients registered in the Yokohama City University...
Autores principales: | Soejima, Yutaro, Kirino, Yohei, Takeno, Mitsuhiro, Kurosawa, Michiko, Takeuchi, Masaki, Yoshimi, Ryusuke, Sugiyama, Yumiko, Ohno, Shigeru, Asami, Yukiko, Sekiguchi, Akiko, Igarashi, Toshihisa, Nagaoka, Shohei, Ishigatsubo, Yoshiaki, Nakajima, Hideaki, Mizuki, Nobuhisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851921/ https://www.ncbi.nlm.nih.gov/pubmed/33522943 http://dx.doi.org/10.1186/s13075-020-02406-6 |
Ejemplares similares
-
Continuous evolution of clinical phenotype in 578 Japanese patients with Behçet’s disease: a retrospective observational study
por: Kirino, Yohei, et al.
Publicado: (2016) -
Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis
por: Ishido, Mizuho, et al.
Publicado: (2017) -
Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease
por: Kirino, Yohei, et al.
Publicado: (2008) -
Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis
por: Ishigatsubo, Y, et al.
Publicado: (2015) -
Adalimumab in the management of Behçet’s disease
por: Ueda, Atsuhisa, et al.
Publicado: (2015)